GW 441756

Overview

GW 441756 is a potent and specific nerve growth factor (NGF) receptor tyrosine kinases A ( TrkA ) inhibitor ( IC 50 =2 nM), which eliminates the BmK NSPK-induced neurite outgrowth.

Application

Products | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Pain | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Cancer | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Trk Receptor | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-18314
• CAS No.: 504433-23-2
• Molecular Formula: C17H13N3O
• Molecular Weight: 275.30
• Purity: 99.85%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.08 mg/mL (7.56 mM); Clear solution
• Availability: In-stock

Source

Original product source